Literature DB >> 27826053

Renal dysfunction in primary hyperparathyroidism; effect of Parathyroidectomy: A retrospective Cohort Study.

C G Nair1, M Babu2, P Jacob3, R Menon4, J Mathew5.   

Abstract

INTRODUCTION: Renal dysfunction associated with primary hyperparathyroidism was studied mostly in patients with mildly asymptomatic or asymptomatic parathyroid disorders. Clinical and biochemical profile of asymptomatic and symptomatic disease vary grossly. The present study analyzed renal function in patients with primary hyperparathyroidism and the relation with clinical features, biochemical features and sonologic changes of kidneys in a cohort of primary symptomatic hyperparathyroidism. STUDY
DESIGN: Cross-sectional study was done in a cohort of surgically proven patients of primary symptomatic hyperparathyroidism. Urinary tract was evaluated with high definition Ultrasonography and renal function was estimated using Modification of Diet in Renal disease (MDRD) Study equation before and after parathyroidectomy. RESULT: Case records 145 patients were studied and there were 44 patients (30.4%) with estimated Glomerular Filtration Rate (eGFR) less than 60 mL/min/1.73 m2. Associated renal complications, coincident hypertension and high serum level of calcium were strongly associated with renal dysfunction. Renal dysfunction marginally improved after 1 year following surgical cure of hyperparathyroidism in 25% of patients with renal dysfunction. There was no detectable change in renal function during the follow up period.
CONCLUSION: There was high prevalence of renal dysfunction among symptomatic hyperparathyroidism. Patients with primary hyperparathyroidism should undergo complete sonological assessment of kidneys which may include presence of nephrocalcinosis and cortical echogenicity. Successful parathyroidectomy prevented deterioration of renal function in most of patients and a significant subset with renal dysfunction showed improvement of functional status.
Copyright © 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Hyperparathyroidism; Nephrocalcinosis; Urolithiasis

Mesh:

Substances:

Year:  2016        PMID: 27826053     DOI: 10.1016/j.ijsu.2016.11.009

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

1.  High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy.

Authors:  Patience Green; Jonathan Zagzag; Dhaval Patel; Lee S Weinstein; William F Simonds; Jenny Blau; Stephen Marx; Electron Kebebew; Nancy Perrier; Naris Nilubol
Journal:  Surgery       Date:  2018-11-07       Impact factor: 3.982

2.  The effect of parathyroidectomy compared to non-surgical surveillance on kidney function in primary hyperparathyroidism: a nationwide historic cohort study.

Authors:  Josephine Matzen; Lise Sofie Bislev; Tanja Sikjær; Lars Rolighed; Mette Friberg Hitz; Pia Eiken; Anne Pernille Hermann; Jens-Erik Beck Jensen; Bo Abrahamsen; Lars Rejnmark
Journal:  BMC Endocr Disord       Date:  2022-01-06       Impact factor: 2.763

3.  Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism.

Authors:  Wenjing Ni; Yue Yuan; Xiaoqiu Chu; Guofang Chen; Xue Han; Jie Li; Xinping Wu; Jianhua Wang; Chao Liu; Shuhang Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-01       Impact factor: 5.555

4.  Improved Mortality Outcomes in Primary Hyperparathyroidism: Significant Benefit of the Dedicated Indian PHPT Registry.

Authors:  Liza Das; Sanjay Kumar Bhadada; Poonam Kumari
Journal:  Indian J Endocrinol Metab       Date:  2021 Nov-Dec

5.  Lower serum calcium levels are a risk factor for a decrease in eGFR in a general non-chronic kidney disease population.

Authors:  Satoru Mizushiri; Makoto Daimon; Hiroshi Murakami; Aya Kamba; Sho Osonoi; Masato Yamaichi; Koki Matsumura; Jutaro Tanabe; Yuki Matsuhashi; Miyuki Yanagimachi; Itoyo Tokuda; Shizuka Kurauchi; Kaori Sawada
Journal:  Sci Rep       Date:  2018-09-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.